Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IPHI
3201
DELISTED
INPHI CORPORATION
IPHI
| $2.63M | ﹤0.01% |
78,910
-4,956
| -6% | -$132K |
|
3202
Schwab US Large-Cap Growth ETF
SCHG
$61.2B
| $2.62M | ﹤0.01% |
400,528
+528
| +0.1% | +$3.27K |
|
|
RHE
3203
DELISTED
Regional Health Properties, Inc.
RHE
| $2.62M | ﹤0.01% |
94,170
+36,123
| +62% | +$926K |
|
3204
CALL
Automatic Data Processing
ADP
$107B
| $2.62M | ﹤0.01% |
29,200
+16,800
| +135% | +$1.41M |
|
|
JE
3205
DELISTED
Just Energy Group Inc
JE
| $2.62M | ﹤0.01% |
13,358
+558
| +4% | +$114K |
|
3206
Vanda Pharmaceuticals
VNDA
$315M
| $2.62M | ﹤0.01% |
312,906
+253,644
| +428% | +$2.08M |
|
3207
PUT
Fluor
FLR
$7.01B
| $2.62M | ﹤0.01% |
48,700
-45,300
| -48% | -$2.13M |
|
|
CBI
3208
PUT
DELISTED
Chicago Bridge & Iron Nv
CBI
| $2.61M | ﹤0.01% |
71,400
-17,800
| -20% | -$637K |
|
|
FTR
3209
CALL
DELISTED
Frontier Communications Corp.
FTR
| $2.61M | ﹤0.01% |
31,140
+19,900
| +177% | +$1.45M |
|
3210
State Street SPDR S&P Oil & Gas Equipment & Services ETF
XES
$355M
| $2.61M | ﹤0.01% |
15,073
+60
| +0.4% | +$9.33K |
|
|
ISEE
3211
PUT
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $2.6M | ﹤0.01% |
61,600
+11,600
| +23% | +$591K |
|
|
SE
3212
CALL
DELISTED
Spectra Energy Corp Wi
SE
| $2.6M | ﹤0.01% |
85,100
-187,500
| -69% | -$5.29M |
|
3213
Invesco Energy Exploration & Production ETF
PXE
$83.4M
| $2.6M | ﹤0.01% |
129,905
-291
| -0.2% | -$5.47K |
|
3214
Omnicell
OMCL
$1.71B
| $2.6M | ﹤0.01% |
93,228
+36,015
| +63% | +$989K |
|
3215
CALL
Akamai
AKAM
$17.1B
| $2.6M | ﹤0.01% |
46,700
-243,000
| -84% | -$12.3M |
|
|
P
3216
CALL
DELISTED
Pandora Media Inc
P
| $2.58M | ﹤0.01% |
288,800
-2,486,200
| -90% | -$24.4M |
|
|
FRN
3217
DELISTED
Invesco Frontier Markets ETF
FRN
| $2.58M | ﹤0.01% |
236,380
+68,608
| +41% | +$705K |
|
|
CBPO
3218
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $2.58M | ﹤0.01% |
22,540
+10,935
| +94% | +$1.28M |
|
3219
ORIX
IX
$43.7B
| $2.58M | ﹤0.01% |
+180,465
| New | +$2.46M |
|
|
FRAN
3220
DELISTED
Francesca's Holdings Corporation
FRAN
| $2.58M | ﹤0.01% |
11,203
+7,856
| +235% | +$1.69M |
|
|
TCF
3221
DELISTED
TCF Financial Corporation Common Stock
TCF
| $2.57M | ﹤0.01% |
72,111
+60,354
| +513% | +$2.01M |
|
3222
Summit State Bank
SSBI
$87.1M
| $2.57M | ﹤0.01% |
266,899
-1,548
| -0.6% | -$15.2K |
|
3223
Metallus
MTUS
$851M
| $2.57M | ﹤0.01% |
282,479
+225,386
| +395% | +$1.65M |
|
3224
CALL
Pacira BioSciences
PCRX
$1.06B
| $2.56M | ﹤0.01% |
48,300
-9,100
| -16% | -$532K |
|
3225
PUT
Vodafone
VOD
$35.9B
| $2.56M | ﹤0.01% |
79,800
-699,174
| -90% | -$21.8M |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.